Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

Genistein and Cancer: Current Status, Challenges, and Future Directions

(2015) Carmela Spagnuolo et al.   Advances in Nutrition

A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors

(2013) Shubham Pant et al.   INVESTIGATIONAL NEW DRUGS

Update on genistein and thyroid: an overall message of safety

(2012) Herbert Marini et al.   Frontiers in Endocrinology

Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line

(2011) Yukun Zhang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Factors Related to the Use of Dietary Supplements by Cancer Survivors

(2009) Leah M. Ferrucci et al.   JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB

(2008) Leigh A Solomon et al.   Journal of Ovarian Research